
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting PPARs for therapy of atherosclerosis: A review
Miao Miao, Xue Wang, Tian Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125008-125008
Closed Access | Times Cited: 22
Miao Miao, Xue Wang, Tian Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125008-125008
Closed Access | Times Cited: 22
Showing 22 citing articles:
Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression
Yunkuo Li, Yujie Pan, Xiaodong Zhao, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 2, pp. 332-345
Open Access | Times Cited: 26
Yunkuo Li, Yujie Pan, Xiaodong Zhao, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 2, pp. 332-345
Open Access | Times Cited: 26
Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor
S Kamata, Akihiro Honda, Ryo Ishikawa, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1523-1523
Open Access | Times Cited: 22
S Kamata, Akihiro Honda, Ryo Ishikawa, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1523-1523
Open Access | Times Cited: 22
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation
Yan Zhang, Xueying Zhang, Shan-Rui Shi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 9
Yan Zhang, Xueying Zhang, Shan-Rui Shi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 9
PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets
Yi Zheng, Mingyan Shao, Yanfei Zheng, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Yi Zheng, Mingyan Shao, Yanfei Zheng, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases
Ziwei Zhou, Meijing Li, Zekuan Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118506-118506
Closed Access | Times Cited: 8
Ziwei Zhou, Meijing Li, Zekuan Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118506-118506
Closed Access | Times Cited: 8
M6A plays a potential role in carotid atherosclerosis by modulating immune cell modification and regulating aging-related genes
Wenpeng Zhao, Yingqi Xu, Jiabao Zhu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Wenpeng Zhao, Yingqi Xu, Jiabao Zhu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Huoxue Tongluo Tablet Enhances Atherosclerosis Efferocytosis by Promoting the Differentiation of Trem2+ Macrophages via PPARγ Signaling Pathway
Xingling He, Ziru Li, Sijing Li, et al.
Phytomedicine (2025) Vol. 140, pp. 156579-156579
Closed Access
Xingling He, Ziru Li, Sijing Li, et al.
Phytomedicine (2025) Vol. 140, pp. 156579-156579
Closed Access
Thermal-crosslinked acellular dermal matrix combined with adipose-derived stem cells to regenerate vascularized adipose tissue
Xing Huang, Siyuan Chen, Lu Lin, et al.
Biomedical Materials (2025) Vol. 20, Iss. 2, pp. 025020-025020
Closed Access
Xing Huang, Siyuan Chen, Lu Lin, et al.
Biomedical Materials (2025) Vol. 20, Iss. 2, pp. 025020-025020
Closed Access
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
Xueying Zhang, Qingqing Lu, Yanjie Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Xueying Zhang, Qingqing Lu, Yanjie Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Integrative analysis of genes provides insights into the molecular and immune characteristics of mitochondria-related genes in atherosclerosis
Zhipeng Zheng, Huimin Lu, Xiaowen Wang, et al.
Genomics (2025) Vol. 117, Iss. 2, pp. 111013-111013
Open Access
Zhipeng Zheng, Huimin Lu, Xiaowen Wang, et al.
Genomics (2025) Vol. 117, Iss. 2, pp. 111013-111013
Open Access
Fatty acid metabolism disorders and potential therapeutic traditional Chinese medicines in cardiovascular diseases
Xianfeng Liu, Xinmei Xu, Tao Zhang, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4976-4998
Closed Access | Times Cited: 9
Xianfeng Liu, Xinmei Xu, Tao Zhang, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4976-4998
Closed Access | Times Cited: 9
Laminaria japonica Aresch-Derived Fucoidan Ameliorates Hyperlipidemia by Upregulating LXRs and Suppressing SREBPs
Yan Zhang, Tian Liu, Zhiqian Qu, et al.
Cardiovascular Therapeutics (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Yan Zhang, Tian Liu, Zhiqian Qu, et al.
Cardiovascular Therapeutics (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
A comparative study of the hypolipidemic effects and mechanisms of action ofLaminaria japonica- andAscophyllum nodosum-derived fucoidans in apolipoprotein E-deficient mice
Tian Liu, Xue Wang, Yanming Wang, et al.
Food & Function (2024) Vol. 15, Iss. 11, pp. 5955-5971
Closed Access | Times Cited: 3
Tian Liu, Xue Wang, Yanming Wang, et al.
Food & Function (2024) Vol. 15, Iss. 11, pp. 5955-5971
Closed Access | Times Cited: 3
Exserolide J ameliorates lipid accumulation in vitro by regulating liver X receptor alpha and peroxisome proliferator-activated receptor alpha proteins
Yan Zhang, Xue Wang, Tian Liu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31861-e31861
Open Access | Times Cited: 3
Yan Zhang, Xue Wang, Tian Liu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31861-e31861
Open Access | Times Cited: 3
ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway
Yanlin Cao, Jianjun Li, Sujun Qiu, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Yanlin Cao, Jianjun Li, Sujun Qiu, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Essential oil from Fructus Alpinia zerumbet ameliorates atherosclerosis by activating PPARγ-LXRα-ABCA1/G1 signaling pathway
Sheng-quan Wang, Jun Xiang, Guangqiong Zhang, et al.
Phytomedicine (2023) Vol. 123, pp. 155227-155227
Closed Access | Times Cited: 7
Sheng-quan Wang, Jun Xiang, Guangqiong Zhang, et al.
Phytomedicine (2023) Vol. 123, pp. 155227-155227
Closed Access | Times Cited: 7
Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications
Vipin Kumar, Megumi Narisawa, Xian Wu Cheng
The FASEB Journal (2024) Vol. 38, Iss. 13
Open Access | Times Cited: 2
Vipin Kumar, Megumi Narisawa, Xian Wu Cheng
The FASEB Journal (2024) Vol. 38, Iss. 13
Open Access | Times Cited: 2
Chondroitin sulfate functionalized nanozymes inhibit the inflammation feedback loop for enhanced atherosclerosis therapy by regulating intercellular crosstalk
Chenglong Wang, Yufeng He, Jun Tang, et al.
International Journal of Biological Macromolecules (2024), pp. 136918-136918
Closed Access | Times Cited: 2
Chenglong Wang, Yufeng He, Jun Tang, et al.
International Journal of Biological Macromolecules (2024), pp. 136918-136918
Closed Access | Times Cited: 2
Bivalent affinity binding-inspired PPARγ immobilization with selective conformation and improved ligand-binding activity
Zilong Zhang, Jiahuan Chen, Lixiang Chen, et al.
Journal of Chromatography A (2024) Vol. 1730, pp. 465141-465141
Closed Access | Times Cited: 1
Zilong Zhang, Jiahuan Chen, Lixiang Chen, et al.
Journal of Chromatography A (2024) Vol. 1730, pp. 465141-465141
Closed Access | Times Cited: 1
Inhibition of hepatitis B virus through PPAR-JAK/STAT pathway modulation by electroacupuncture and tenofovir disoproxil fumarate combination therapy
Yan Yang, Feilin Ge, Luo Chen, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113304-113304
Open Access
Yan Yang, Feilin Ge, Luo Chen, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113304-113304
Open Access
Cajaninstilbene Acid and Its Derivative as Multi-Therapeutic Agents: A Comprehensive Review
Wen Hou, Lejun Huang, Jinyang Wang, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5440-5440
Open Access
Wen Hou, Lejun Huang, Jinyang Wang, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5440-5440
Open Access
Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: focus on PPARs, LXRs, and PCSK9
Marcella Palumbo, M. Ugolotti, Francesca Zimetti, et al.
Atherosclerosis Plus (2024)
Open Access
Marcella Palumbo, M. Ugolotti, Francesca Zimetti, et al.
Atherosclerosis Plus (2024)
Open Access